Exosomes promote cetuximab resistance via the PTEN/Akt pathway in colon cancer cells

Cetuximab is widely used in patients with metastatic colon cancer expressing wildtype KRAS. However, acquired drug resistance limits its clinical efficacy. Exosomes are nanosized vesicles secreted by various cell types. Tumor cell-derived exosomes participate in many biological processes, including...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	S. Zhang, Y. Zhang, J. Qu, X. Che, Y. Fan, K. Hou, T. Guo, G. Deng, N. Song, C. Li, X. Wan, X. Qu, Y. Liu
Format:	Artigo
Sprog:	Inglês
Udgivet:	Associação Brasileira de Divulgação Científica 2017-11-01
Serier:	Brazilian Journal of Medical and Biological Research
Fag:	Cetuximab Exosome PTEN Akt Colon cancer
Online adgang:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2018000100609&lng=en&tlng=en
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!